Nephrology Doctors in Riverside, RI Accepting Medicare
8 Nephrology doctors found. Showing 1 - 8
 Reginald Y Gohh, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
 Susie Lee Hu, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
J Gary Abuelo, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
Katherine F Richman, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
Douglas G Shemin, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 404-649-4060 Fax: 401-649-4061 |
Dr. Jie Tang, MD, MS, MPH Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
John W. O'bell, MD Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
George P Bayliss, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 302a, Riverside, RI 02915 Phone: 401-649-4060 Fax: 401-649-4061 |
News Archive
Positive results from international study of Oncotype DX breast cancer RS
Genomic Health, Inc. today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX® breast cancer Recurrence Score® (RS) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive, postmenopausal breast cancer patients who are treated with either anastrozole or tamoxifen.
FDA warns patients and physicians about the efficacy of Plavix treatment
The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
Leukaemia drug could slow progression of Duchenne muscular dystrophy
A drug commonly used to treat leukaemia is showing potential as a treatment that could slow the progression of the muscle-wasting condition, Duchenne muscular dystrophy.
IU-connected startup working to enable precision medicine for mental health issues, chronic pain
A new startup company founded on science developed at Indiana University is working to enable precision medicine by commercializing the first objective tests for mental health issues, including suicide risk, post-traumatic stress disorder and depression, and for pain, all of which historically have been difficult to measure for patients and health care providers alike.
› Verified 5 days ago
Internal Medicine
Psychiatry & Neurology
Gastroenterology
Nephrology
Endocrinology, Diabetes & Metabolism
Family Medicine
Geriatric Medicine
Pulmonary Disease
Pediatrics
Critical Care Medicine
Infectious Disease
Anesthesiology
Pathology